The rationality of anti-malaria drug prescriptions and its conformity with the national protocol for treatment of malaria in Wad Medani, Sudan

dc.contributor.authorAli A. A. Saeed
dc.contributor.authorSalah I. Kheder
dc.date.accessioned2023-01-19T11:31:09Z
dc.date.available2023-01-19T11:31:09Z
dc.date.issued2010
dc.description.abstractThis study was conducted at Wad Medani, Gezera State, Sudan in February 2010, to determine the pattern of anti malarial drugs prescriptions and to test their conformity to the National Protocol for treatment of malaria. One hundred sixty prescriptions were collected and reviewed. The majority of prescriptions (95.6%) were written by house officers and medical officers. The most common anti-malarial drug prescribed was “Artesunate 100 mg and Sulfadoxine 500 mg, Pyrimethamine 25 mg” combination (75%) followed by Quinine injections (15.6%) Artmether injections (5.6%), Lumefantrine and Artemether combination (1.9%) and Quinine tablets (1.9%). This study revealed that although most of the prescriptions conform to the National Protocol for treatment of malaria, regarding the first line therapy of uncomplicated malaria, most prescriptions were irrational (61.2%)
dc.identifier.urihttp://dspace.napata.edu.sd/handle/123456789/259
dc.language.isoen
dc.publisherNational College
dc.titleThe rationality of anti-malaria drug prescriptions and its conformity with the national protocol for treatment of malaria in Wad Medani, Sudan
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
The rationality of anti-malaria drug prescriptions and its conformity with the national protocol for treatment of malaria in Wad Medani, Sudan.pdf
Size:
1.72 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Collections